Results from the long-term extension of the Phase III TRAILBLAZER-ALZ 2 trial (NCT04437511) showed sustained benefits with ...

A Wellington man is being held on $2 million bond after authorities say he exploited his elderly mother, siphoning off more ...

A Scots chemist believes drugs to treat Alzheimer's disease will be available within five years. Professor David MacMillan, ...